Indisetron

Drug Profile

Indisetron

Alternative Names: N-3389; Sinseron

Latest Information Update: 31 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nisshin Pharma
  • Developer Kyorin Pharmaceutical
  • Class Antiemetics; Organic bridged compounds; Pyrazoles; Small molecules
  • Mechanism of Action Serotonin 3 receptor antagonists; Serotonin 4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Nausea and vomiting

Most Recent Events

  • 20 Sep 2004 Launched for Nausea and vomiting in Japan (PO)
  • 26 Aug 2004 Nisshin formed a cooperative sales agreement with Yakult Honsha for indisetron
  • 11 Sep 2000 Phase-II clinical trials for Nausea and vomiting in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top